Tag: Luminor DCB
Five-year RCT data provide upbeat message on Luminor paclitaxel-coated balloon’s safety...
NOTE: This video is ONLY available to watch in selected countries and geographies
The EffPac trial was a prospective, multicentre, randomised controlled trial (RCT)...
Episode 1: Luminor DCB in the femoropopliteal segment: Outstanding safety and...
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Episode 2: Experience of Luminor DCB in the below-the-knee segment
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Episode 3: Not all DCBs are the same: Luminor TransferTech nanotechnology...
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
“No signal of increased risk of long-term mortality” with paclitaxel-coated Luminor...
An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two...
Luminor DCB now reimbursed in France
Luminor 18 and Luminor 35 drug-coated balloons (DCB; iVascular) are now listed on the French LPPR list for de novo lesions of the femoropopliteal...
TINTIN trial shows “impressive” results at six months
The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...
Novel paclitaxel-nano-coated balloon achieves lower incidence of restenosis than plain balloon...
Two-year results of EffPac—a randomised controlled trial to assess the safety and efficacy of a novel drug-coated balloon (DCB) with a nanotechnology coating—have been...
Enrolment complete in T.I.N.T.I.N. study
iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study.
The effectiveness...
